Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
Human Gene Therapy|August 29, 2020
Generation of a Novel Oncolytic Vaccinia Virus Using the IHD-W StrainJaeil Shin, Soon-Oh Hong, Minju Kim, et al.Nature Communications|June 15, 2023
A dorsomedial prefrontal cortex-based dynamic functional connectivity model of ruminationJungwoo Kim, Jessica R Andrews-Hanna, Hedwig Eisenbarth, et al.Breast Cancer Research and Treatment|August 14, 2019
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)Ji-Yeon Kim, Eunjin Lee, Kyunghee Park, et al.Oncoimmunology|September 18, 2018
Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancerSong Ee Park, Kyunghee Park, Eunjin Lee, et al.Scientific Reports|April 9, 2026
Intraoperative video-based artificial intelligence model exceeding surgeon accuracy for predicting severe fibrosis in minimally invasive liver surgeryNamkee Oh, Bogeun Kim, Sunghyo An, et al.Molecular Therapy Oncolytics|September 20, 2023
Transgenic viral expression of PH-20, IL-12, and sPD1-Fc enhances immune cell infiltration and anti-tumor efficacy of an oncolytic virusSoon-Oh Hong, Joonsung Kim, Sungmin Lee, et al.Journal of Pediatric Psychology|May 17, 2019
Parental Involvement and Executive Function in Emerging Adults with Type 1 DiabetesCynthia A Berg, Deborah J Wiebe, Eunjin Lee Tracy, et al.Genome Biology|July 23, 2017
Characterization of background noise in capture-based targeted sequencing dataGahee Park, Joo Kyung Park, Seung-Ho Shin, et al.Toxicology|April 10, 2012
High dose bisphenol A impairs hippocampal neurogenesis in female mice across generationsYoung Jung Jang, Hee Ra Park, Tae Hyung Kim, et al.International Journal of Cancer|February 6, 2019
Molecular alterations and poziotinib efficacy, a pan-HER inhibitor, in human epidermal growth factor receptor 2 (HER2)-positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2-positive breast cancer patientsJi-Yeon Kim, Eunjin Lee, Kyunghee Park, et al.Pageof 12